deltatrials
Unknown NA INTERVENTIONAL NCT00550992

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia (Interfant06)

International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia

Sponsor: Associazione Italiana Ematologia Oncologia Pediatrica

Conditions Leukemia
Interventions allogeneic bone marrow transplantation allogeneic hematopoietic stem cell transplantation anti-thymocyte globulin asparaginase busulfan cyclophosphamide cyclosporine cytarabine daunorubicin hydrochloride etoposide leucovorin calcium melphalan mercaptopurine methotrexate mitoxantrone hydrochloride pegaspargase prednisolone prednisone therapeutic hydrocortisone thioguanine umbilical cord blood transplantation vincristine sulfate
Updated 9 times since 2017 Last updated: Jul 29, 2019 Started: Jan 31, 2006 Primary completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Leukemia and is currently ongoing. Associazione Italiana Ematologia Oncologia Pediatrica leads this study, which shows 9 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotUnknown Status~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotUnknown~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Mar 2025 — Sep 2025 [monthly]

    Unknown NA

  3. Sep 2024 — Mar 2025 [monthly]

    Unknown NA

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  5. Oct 2021 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Recruiting NA

  2. Aug 2019 — Jan 2021 [monthly]

    Recruiting NA

    Status: Unknown Status → Recruiting

  3. Jun 2018 — Aug 2019 [monthly]

    Unknown Status NA

  4. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Associazione Italiana Ematologia Oncologia Pediatrica
  • Australian and New Zealand Children's Oncology Group
  • BFM Austria
  • BFM Germany
  • CLCG France Belgium Portugal
  • COALL Germany
  • CORS Monza Italy
  • CPH, Czech republic
  • DFCI consortium USA
  • Dutch Childhood Oncology Group
  • FRALLE France
  • Hong Kong Government
  • MD Anderson USA
  • NOPHO Scandinavian countries
  • PINDA, Chile
  • PPLLSG Poland
  • SJCRH USA
  • Seattle USA
  • UKCCSG United Kingdom
Data source: Dutch Childhood Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States , Brussels, Belgium , Hamburg, Germany , Hanover, Germany , Houston, United States , London, United Kingdom , Memphis, United States , Monza, Italy , Nantes, France , Prague, Czechia and 3 more locations